KY4.XFRA Overview
Upcoming Projects (KY4.XFRA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (KY4.XFRA)
-
A Third Look: Discussing the top-line results from Amgen and Kyowa Kirin's Rocatinlimab Phase 3 IGNITE study in adults with moderate to severe atopic dermatitis
Tickers: AMGN, KY4.XFRA
Executed On: Apr 11, 2025 at 01:00 PM EDT -
A second look: Discussing the top-line results from Amgen and Kyowa Kirin's Rocatinlimab Phase 3 IGNITE study in adults with moderate to severe atopic dermatitis
Tickers: AMGN, KY4.XFRA
Executed On: Apr 04, 2025 at 12:45 PM EDT -
Discussing the top-line results from Amgen and Kyowa Kirin's Rocatinlimab Phase 3 IGNITE study in adults with moderate to severe atopic dermatitis
Tickers: AMGN, KY4.XFRA
Executed On: Apr 02, 2025 at 12:30 PM EDT
Upcoming & Overdue Catalysts (KY4.XFRA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (KY4.XFRA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
